SI-BONE, Inc. (SIBN)
NASDAQ: SIBN · Real-Time Price · USD
14.74
-0.36 (-2.38%)
Oct 17, 2025, 4:00 PM EDT - Market closed
SI-BONE Market Cap
SI-BONE has a market cap or net worth of $635.90 million as of October 17, 2025. Its market cap has increased by 12.14% in one year.
Market Cap
635.90M
Enterprise Value
527.29M
1-Year Change
12.14%
Ranking
Category
Stock Price
$14.74
Market Cap Chart
Since October 17, 2018, SI-BONE's market cap has increased from $218.80M to $635.90M, an increase of 190.62%. That is a compound annual growth rate of 16.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 635.90M | 8.15% |
| Dec 31, 2024 | 587.97M | -30.84% |
| Dec 29, 2023 | 850.12M | 81.20% |
| Dec 30, 2022 | 469.15M | -36.93% |
| Dec 31, 2021 | 743.81M | -23.13% |
| Dec 31, 2020 | 967.59M | 79.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |